Would you like to know more about the GOLDEN study? Contact Us

What differentiates the GOLDEN study from other trials related to GA or AMD?

Unlike other treatments meant to help people living with GA or AMD, the GOLDEN study is for an investigational drug that has the potential to treat both eyes through one monthly injection. And rather than an injection directly into an eye, the investigational drug is given through an injection just beneath the skin (subcutaneous) in either the abdomen or thigh. This means it has the potential of being more tolerable and more convenient than other treatments for this condition.

In addition, the investigational drug has a unique mechanism by targeting the genes shown to be responsible for the genetic causes of AMD.